To evaluate the in vivo safety and efficacy of hair care formulation in terms of reduction in dandruff and sebum reduction on healthy female participants - Nil

SLJ Solution Logistics LLP0 个研究点目标入组 30 人开始时间: 2026年7月13日最近更新: 2026年8月3日

试验速览

暂无简介。

•Indian Female participants
•Healthy subjects
•Skin is healthy on the studied anatomic unit4)Having moderate to severe dandruff

•For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
•Having refused to give her assent by not signing the consent form.
•Taking part in another study liable to interfere with this study.
•Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months).
•Having a progressive asthma.
•Being epileptic.
•Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months).
•Having cutaneous hypersensitivity.
•Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
•Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
•Having consumed caffeine-based products (coffee, cola, tea ), alcohol, highly spiced foods and/or smoked in the two hours preceding the measurements.
•Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
•Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
•Having applied a cosmetic product (included make-up) or skin care product on the studied areas the day of the study (only face cleaned with water is accepted)

发起方

SLJ Solution Logistics LLP